Skip to main content
IDDO Logo
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

All Tools and Resources

Pharmacology Data Management and Statistical Analysis Plan

Document

Pharmacology PK/PD Day 7 lumefantrine Statistical Analysis Plan

Document

Pharmacology Questionnaire

Document

Piperaquine Survival Assays (PSA) to evaluate the in-vitro and ex-vivo susceptibility of Plasmodium falciparum to piperaquine

Procedure

 

 

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after ArtemetherLumefantrine and Artesunate-Amodiaquine

Document

Post-exposure prophylaxis in the clinical trial facility

Procedure

 

 

Pre- and post-admission team meetings

Procedure

 

 

Pre-trial site assessment

Procedure

Predicting Ebola diagnosis and outcome using machine learning: A retrospective cohort study on the 2014-16 West African epidemic

Document

Preparation of Culture Medium

Procedure

 

 

Pagination

  • First page « First
  • Previous page ‹‹ Prev
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Current page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • …
  • Next page Next ››
  • Last page Last »

  • Navigation
    • About
  • Contact
    • info@iddo.org
  • Socials
    • LinkedIn
  • Newsletters
    • IDDO Newsletter
IDDO Footer logo
© 2026 Infectious Diseases Data Observatory
  • Cookies |
  • Privacy Notice |
  • Accessibility |
  • Sitemap |
  • Terms of use